Display options
Share it on

ACS Med Chem Lett. 2016 May 31;7(7):681-5. doi: 10.1021/acsmedchemlett.6b00084. eCollection 2016 Jul 14.

Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1.

ACS medicinal chemistry letters

Athanasios Stamogiannos, Athanasios Papakyriakou, Francois-Xavier Mauvais, Peter van Endert, Efstratios Stratikos

Affiliations

  1. National Center for Scientific Research Demokritos , Agia Paraskevi GR-15310, Athens, Greece.
  2. Institut National de la Santé et de la Recherche Médicale, Unité1151; Université Paris Descartes, Sorbonne Paris Cité; Centre National de la Recherche Scientifique, Unité 8253 , 75015 Paris, France.

PMID: 27437077 PMCID: PMC4948014 DOI: 10.1021/acsmedchemlett.6b00084

Abstract

We employed virtual screening followed by in vitro evaluation to discover novel inhibitors of ER aminopeptidase 1, an important enzyme for the human adaptive immune response that has emerged as an attractive target for cancer immunotherapy and the control of autoimmunity. Screening hits included three structurally related compounds carrying the (E)-N'-((1H-indol-3-yl)methylene)-1H-pyrazole-5-carbohydrazide scaffold and (2-carboxylatophenyl)sulfanyl-ethylmercury as novel ERAP1 inhibitors. The latter, also known as thimerosal, a common component in vaccines, was found to inhibit ERAP1 in the submicromolar range and to present strong selectivity versus the homologous aminopeptidases ERAP2 and IRAP. Cell-based analysis indicated that thimerosal can effectively reduce ERAP1-dependent cross-presentation by dendritic cells in a dose-dependent manner.

Keywords: ERAP1; ERAP2; IRAP; aminopeptidase; antigenic peptide; docking; immune system; inhibitor

References

  1. J Med Chem. 2015 Feb 12;58(3):1524-43 - PubMed
  2. J Toxicol. 2012;2012:373678 - PubMed
  3. Nat Struct Mol Biol. 2011 May;18(5):604-13 - PubMed
  4. Am J Public Health. 2008 Feb;98(2):244-53 - PubMed
  5. Science. 2009 Jul 10;325(5937):213-7 - PubMed
  6. J Immunol. 2015 Sep 15;195(6):2842-51 - PubMed
  7. J Appl Toxicol. 2013 Aug;33(8):700-11 - PubMed
  8. Cancer Res. 2015 Mar 1;75(5):824-34 - PubMed
  9. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41 - PubMed
  10. Biochem J. 2011 Apr 15;435(2):411-20 - PubMed
  11. Curr Opin Immunol. 2013 Feb;25(1):90-6 - PubMed
  12. J Immunol. 2007 Feb 15;178(4):2241-8 - PubMed
  13. Curr Pharm Des. 2009;15(31):3656-70 - PubMed
  14. J Immunol. 2010 Aug 1;185(3):1584-92 - PubMed
  15. Curr Opin Chem Biol. 2014 Dec;23:1-7 - PubMed
  16. Oncoimmunology. 2014 Jan 1;3(1):e27568 - PubMed
  17. J Comput Chem. 2010 Jan 30;31(2):455-61 - PubMed
  18. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7745-50 - PubMed
  19. Biochemistry. 2012 Jan 10;51(1):286-95 - PubMed
  20. EMBO Rep. 2011 Dec 01;12(12):1257-64 - PubMed
  21. Biochim Biophys Acta. 2010 Jan;1803(1):72-94 - PubMed
  22. Methods Mol Biol. 2013;960:351-7 - PubMed
  23. Inorg Chem. 2004 May 17;43(10):3038-47 - PubMed
  24. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19890-5 - PubMed
  25. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W409-14 - PubMed
  26. Ann Rheum Dis. 2016 May;75(5):916-23 - PubMed
  27. Environ Health Perspect. 2006 Jul;114(7):1083-91 - PubMed
  28. J Chem Inf Model. 2012 Jul 23;52(7):1757-68 - PubMed
  29. J Biochem. 1999 May;125(5):931-8 - PubMed

Publication Types